ATE259654T1 - Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen - Google Patents

Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen

Info

Publication number
ATE259654T1
ATE259654T1 AT99927966T AT99927966T ATE259654T1 AT E259654 T1 ATE259654 T1 AT E259654T1 AT 99927966 T AT99927966 T AT 99927966T AT 99927966 T AT99927966 T AT 99927966T AT E259654 T1 ATE259654 T1 AT E259654T1
Authority
AT
Austria
Prior art keywords
prophylaxis
microorganisms
control
pharmaceutical preparations
surfaces infected
Prior art date
Application number
AT99927966T
Other languages
English (en)
Inventor
Pieter Jacob Swart
Maria Elizabeth Kuipers
Dirk Klaas Fokke Meijer
Robert Johan Joseph Hageman
Den Berg Jeroen Johannes M Van
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98203765A external-priority patent/EP0974360A3/de
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE259654T1 publication Critical patent/ATE259654T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT99927966T 1998-06-26 1999-06-28 Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen ATE259654T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL1009505 1998-06-26
NL1010284 1998-10-09
EP98203765A EP0974360A3 (de) 1998-06-26 1998-11-06 Pharmazeutische Präparate zur Bekämpfung oder Prophylaxe von Mikroorganismen infizierten Oberflächen
PCT/EP1999/004067 WO2000000214A2 (en) 1998-06-26 1999-06-28 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms

Publications (1)

Publication Number Publication Date
ATE259654T1 true ATE259654T1 (de) 2004-03-15

Family

ID=27239422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927966T ATE259654T1 (de) 1998-06-26 1999-06-28 Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen

Country Status (8)

Country Link
EP (1) EP1089755B1 (de)
JP (1) JP2002519332A (de)
AT (1) ATE259654T1 (de)
AU (1) AU771077B2 (de)
CA (1) CA2332127A1 (de)
DE (1) DE69914911T2 (de)
NZ (1) NZ509101A (de)
WO (1) WO2000000214A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0111718A (pt) * 2000-06-16 2003-09-09 Hercules Inc Peptìdeos quimicamente modificados, composições e métodos de produção e uso
CA2412513A1 (en) * 2000-06-22 2001-12-27 San Diego State University Foundation Modulators of recombination and methods for producing and using the same
EP1347776A2 (de) * 2001-01-05 2003-10-01 Intercell Biomedizinische Forschungs- und Entwicklungs AG Gebrauch von polykationen als entzündungshemmende mittel
US7244438B2 (en) 2001-01-05 2007-07-17 Intercell Ag Uses for polycationic compounds
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
ATE399562T1 (de) * 2001-08-23 2008-07-15 Westgate Biolog Ltd Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
WO2003094952A1 (en) * 2002-05-10 2003-11-20 Agennix Incorporated Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
WO2005016372A1 (en) * 2003-03-25 2005-02-24 Advitech Solutions Inc. Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals
CA2527904A1 (en) 2003-06-06 2005-05-26 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
WO2007065128A2 (en) * 2005-11-30 2007-06-07 Auburn University Human alpha-defensins inhibit interleukin-1beta release
WO2008017661A1 (en) 2006-08-07 2008-02-14 Novozymes A/S Enzyme granules for animal feed
CN103168928A (zh) 2006-08-07 2013-06-26 诺维信公司 用于动物饲料的酶团粒
KR101406743B1 (ko) 2009-01-13 2014-06-20 페르가뭄 아베 상처, 흉터, 수술 후 유착 형성을 치료하기 위한 히알루론산 함유 조성물
FR2967160B1 (fr) * 2010-11-09 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la dermatopontine et composition cosmetique les comprenant
US20140315789A1 (en) * 2011-11-23 2014-10-23 Newsouth Innovations Pty Limited Antimicrobial peptides and uses thereof
CN108033995B (zh) * 2017-12-19 2020-12-29 渤海大学 两种来源于大黄鱼肌联蛋白的ace抑制肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ241936A (en) * 1991-03-13 1994-03-25 Morinaga Milk Industry Co Ltd Antimicrobial peptide and its use in an antimicrobial composition
DE69223844T2 (de) * 1991-04-24 1998-04-16 Morinaga Milk Industry Co Ltd Antimikrobielles Peptid und antimikrobieller Wirkstoff
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins

Also Published As

Publication number Publication date
DE69914911T2 (de) 2004-12-09
DE69914911D1 (de) 2004-03-25
WO2000000214A3 (en) 2000-03-30
EP1089755B1 (de) 2004-02-18
AU4512499A (en) 2000-01-17
EP1089755A2 (de) 2001-04-11
WO2000000214A2 (en) 2000-01-06
CA2332127A1 (en) 2000-01-06
JP2002519332A (ja) 2002-07-02
AU771077B2 (en) 2004-03-11
NZ509101A (en) 2003-07-25

Similar Documents

Publication Publication Date Title
ATE259654T1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
AU3698697A (en) Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicament
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
BR9611565A (pt) Peptideo antimicrobiano, sistema de expressão recombinante para produçao de peptideo antimicrobiano, célula hospedeira recombinante ou progênie da mesma, composiçao farmacêutia e ambiental antimicrobiana, processo para produzir peptideo, para evitar o crescimento de um virus ou microbio, para inativar a endoxina de bacterias gram-negativas e para tratar o evitar a infecçao por micróbios ou virus em um induvìduo, e, anticorpos.
IL157041A0 (en) Monoclonal antibodies to the clfa protein and method of use in treating and preventing infections
DK0832119T3 (da) Histatinbaserede peptider mod svamp og bakterier
ATE427116T1 (de) Behandlung von bakteriellen infektionen
EP1283050A3 (de) Verbesserte Arzneimittelzusammensetzungen, welche ein bakterizides Permeabilität erhöhendes Protein enthalten
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
ES2170239T3 (es) Peptidos antifungicos de d-aminoacidos basados en histatina.
HUP0202235A2 (hu) Tartósított gyógyászati készítmények
AU3657600A (en) Biologically active compounds of (ganoderma pfeifferi) dms 13239
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE3780644T2 (de) Glykopeptid-antibiotika.
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
DE69631381D1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE413170T1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus
EP0974360A3 (de) Pharmazeutische Präparate zur Bekämpfung oder Prophylaxe von Mikroorganismen infizierten Oberflächen
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
AU2396900A (en) Treatment and prevention of hiv and other viral infections

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties